Haziel Eleazar Dzib Baak

Mr. Haziel Eleazar Dzib Baak

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
ADAngel de Jesús Dzul-Beh
Angel de Jesús Dzul-Beh
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
AGAvel Adolfo González-Sánchez
Avel Adolfo González-Sánchez
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
RORolffy Ortiz-Andrade
Rolffy Ortiz-Andrade
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas

23 April 2024 in Plants
Verified
Journal Article
Open access
PDF file
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
LCLuz María Calvo-Irabien
Luz María Calvo-Irabien
ADAngel de Jesús Dzul-Beh
Angel de Jesús Dzul-Beh
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
RGRosa Grijalva-Arango
Rosa Grijalva-Arango
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
Staphylococcus aureus infections are prevalent in healthcare and community environments. Methicillin-resistant S. aureus is catalogued as a superbug of high priority among the pathogens. This Gram-positive coccus can form biofilms and produce toxins, leading to persistent infection and antibiotic resistance. Limited effective antibiotics have encouraged the development of innovative strategies, with a particular emphasis on resistance mechanisms and/or virulence factors. Medicinal aromatic plants have emerged as promising alternative sources. This study investigated the antimicrobial, antibiofilm, and antihemolysis properties of three different chemotypes of Lippia origanoides essential oil (EO) against susceptible and drug-resistant S. aureus strains. The chemical composition of the EO was analyzed using GC-MS, revealing high monoterpene concentrations, with carvacrol and thymol as the major components in two of the chemotypes. The third chemotype consisted mainly of the sesquiterpene β-caryophyllene. The MIC values for the two monoterpene chemotypes ranged from 62.5 to 500 µg/mL for all strains, whereas the sesquiterpene chemotype showed activity against seven strains at concentrations of 125–500 µg/mL, which is the first report of its anti-S. aureus activity. The phenolic chemotypes inhibited biofilm formation in seven S. aureus strains, whereas the sesquiterpene chemotype only inhibited biofilm formation in four strains. In addition, phenolic chemotypes displayed antihemolysis activity, with IC50 values ranging from 58.9 ± 3.8 to 128.3 ± 9.2 µg/mL. Our study highlights the importance of L. origanoides EO from the Yucatan Peninsula, which has the potential for the development of anti-S. aureus agents.

Verified
Journal Article
Open access
PDF file
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
ADAngel de Jesús Dzul-Beh
Angel de Jesús Dzul-Beh
RRRey Fernando Rosado-Manzano
Rey Fernando Rosado-Manzano
CGCarlos Gracida-Osorno
Carlos Gracida-Osorno
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
Urinary tract infections (UTI) are a severe public health problem and are caused mainly by the uropathogenic Escherichia coli (UPEC). Antimicrobial resistance and limited development of new antimicrobials have led to the reuse of old antibiotics such as fosfomycin. The aim of this study was to evaluate the in vitro efficacy of fosfomycin on a collection of multidrug-resistant (MDR) UPEC and the degradative activity on biofilm producers. A total of 100 MDR UPEC clinical isolates were collected from patients at Mexican second- and third-level hospitals. Microorganism identification was performed using an automated system, the evaluation of the susceptibility of clinical isolates to fosfomycin was performed using the resazurin microtiter assay, and the identification of biofilm producers and the effect of fosfomycin in biofilms were evaluated using the crystal violet method. Among planktonic MDR UPEC, 93% were susceptible to fosfomycin. Eighty-three MDR UPEC were categorized as weak (39.8%), moderate (45.2%), and strong (14.5%) biofilm producers. Fosfomycin exhibited degradative activity ranging from 164.4 µg/mL to 1045 µg/mL. Weak producers required statistically lower concentrations of fosfomycin to destroy the biofilm, contrary to moderate and strong producers. In conclusion, fosfomycin could be an option for the treatment of infections caused by MDR UPEC, for which the antimicrobial treatment is more often becoming limited.

4 September 2023
Verified
Journal Article
Open access
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
ADAngel de Jesús Dzul-Beh
Angel de Jesús Dzul-Beh
RRRey Fernando Rosado-Manzano
Rey Fernando Rosado-Manzano
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
Las unidades de cuidados intensivos (UCI) son el epicentro de la resistencia a los antimicrobianos (RAM) y las infecciones en estas áreas son causadas principalmente por bacterias Gram-negativas (BGN). describir la frecuencia y los patrones de RAM en BGN aisladas de muestras clínicas de pacientes de las UCI de un hospital de tercer nivel en Mérida, Yucatán. describir la frecuencia y los patrones de RAM en BGN aisladas de muestras clínicas de pacientes de las UCI de un hospital de tercer nivel en Mérida, Yucatán. se identificaron 433 BGN y Klebsiella pneumoniae fue el patógeno más prevalente (n = 117; 27.02%). La mayoría de las BGN aisladas se obtuvieron de secreciones bronquiales (n = 163). En general, las BGN mostraron altas tasas de resistencia a ampicilina (89.48%), ampicilina/sulbactam (66.85%), cefalosporinas (58.52-93.81%), tobramicina (58.06%) y tetraciclina (61.73%). El 73.90% y el 68.53% de las BGN exhibieron perfiles multidrogorresistentes y microorganismos altamente resistentes a fármacos, respectivamente, y 47.54% de los aislamientos de Acinetobacter baumannii mostró perfil de drogorresistencia extendida. El 80.33% de los A. baumannii fue resistente a carbapenémicos y el 83.76% de las K. pneumoniae fueron productoras de BLEE. nuestros datos podrían mejorar la terapia antimicrobiana empírica y el programa de control de infecciones.

14 December 2024 in Plants
Verified
Journal Article
Open access
PDF file
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
ADAngel de Jesús Dzul-Beh
Angel de Jesús Dzul-Beh
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
AGAvel González
Avel González
CNCarlos Javier Quintal Novelo
Carlos Javier Quintal Novelo
(1) Background: Carbapenem-resistant Acinetobacter baumannii (CBRAB) and Pseudomonas aeruginosa (CBRPA) are critical and high-priority pathogens that require new therapeutic developments. Medicinal plants are valuable pharmaceutical resources. This study explored the anti-infective properties of Mayan plants, Bignonia potosina, and Thouinia paucidentata. (2) Methods: Plant parts were extracted using n-hexane, and their ability to inhibit bacterial growth and counteract resistance mechanisms and virulence factors in CBRAB and CBRPA was assessed. GC-MS analysis of the composition of the non-polar extracts and chemometric techniques correlated the phytoconstituents with anti-infective properties. (3) Results: Bignonia potosina liana and flower extracts exhibited potent antibacterial activity against A. baumannii strains (MIC 15.7 to 250 µg/mL) and moderate activity against P. aeruginosa strains (MIC 250 to 1000 µg/mL). Thouinia paucidentata leaf extract at 1000 µg/mL reduced imipenem MIC by 2048-fold for CBRAB, and B. potosina flower extract significantly inhibited A. baumannii catalase activity (at 62.5 µg/mL) and reduced P. aeruginosa pyocyanin production (at 1000 µg/mL). Chemometric analysis identified fatty acids, fatty acid amides, terpenes, and higher alkanes as contributors to their anti-infective properties. (4) Conclusions: This study highlights the potential of medicinal plants in the development of novel anti-infective therapies against CBRAB and CBRPA with various targets.

18 December 2025 in Microbiology Research
Verified
Journal Article
Open access
PDF file
HMHernando Maldonado-Pérez
Hernando Maldonado-Pérez
JPJuan Pablo Pinzon
Juan Pablo Pinzon
Gloria Molina SalinasGloria Molina Salinas
Gloria Molina Salinas
AGAvel González
Avel González
HBHaziel Eleazar Dzib Baak
Haziel Eleazar Dzib Baak
AUAndrés Humberto Uc-Cachón
Andrés Humberto Uc-Cachón
Background: Infections caused by Staphylococcus aureus are a health problem worsened by antibiotic resistance. New drugs, including those inhibiting virulence and resistance mechanisms, are needed. This study aimed to evaluate the anti-growth, anti-virulence, and anti-biofilm activities of Trametes villosa. (2) Methods: Fractions were obtained from the basidiomata of T. villosa. Anti-growth, anti-hemolysis, and anti-biofilm activities were tested against S. aureus strains using resazurin microtiter, blood cell lysis, and crystal violet assays, respectively. Cytotoxicity was evaluated in Vero and HaCaT cells using sulforhodamine B. The active fractions were subjected to GC-MS analysis and molecular docking with S. aureus quorum-sensing receptors. Results: The n-hexane and ethyl acetate (EtOAc) fractions exhibited anti-growth activity against all strains (MIC: 31.2–2000 µg/mL). These fractions also displayed anti-hemolysis (IC50 = 33.8 ± 1.1–53.8 ± 5.1 µg/mL) and anti-biofilm formation activity (IC50 = 106.6 ± 4.8–383.4 ± 31.4 µg/mL), while exhibiting low cytotoxicity in Vero and HaCat. GC-MS analysis revealed that both active fractions mainly contained alkanes, aldehydes, and fatty acids. Molecular docking revealed that isovanillic acid, identified in the EtOAc fraction, exhibited optimal interactions with S. aureus quorum-sensing receptors AgrA and SarA. (4) Conclusions: Our research highlights the potential of T. villosa as a source of bioactive compounds effective against S. aureus.